Suchergebnisse - "Ataga, Kenneth I"

PubPharm (8)

1

Riociguat in patients with sickle cell disease and hypertension or proteinuria (STERIO-SCD) : a randomised, double-blind, placebo controlled, phase 1-2 trial

enthalten in: The Lancet. Haematology | 2024

von Gladwin, M. | Gordeuk, V. | Desai, P. | +26

2

Effect of crizanlizumab on pain crises in subgroups of patients with sickle cell disease : A SUSTAIN study analysis

enthalten in: American journal of hematology | 2019

von Kutlar, A. | Kanter, J. | Liles, D. | +8

3

Effect of eptifibatide on inflammation during acute pain episodes in sickle cell disease

enthalten in: American journal of hematology | 2018

von Brittain, J. | Anea, C. | Desai, P. | +6

4

Crizanlizumab for the Prevention of Pain Crises in Sickle Cell Disease

enthalten in: The New England journal of medicine | 2017

von Ataga, K. | Kutlar, A. | Kanter, J. | +13

CommentIn: N Engl J Med. 2017 Feb 2;376(5):485-487. - PMID 28146663

5

A dose-escalation phase IIa study of 2,2-dimethylbutyrate (HQK-1001), an oral fetal globin inducer, in sickle cell disease

enthalten in: American journal of hematology | 2013

von Kutlar, A. | Reid, M. | Inati, A. | +8

6

A pilot study of eptifibatide for treatment of acute pain episodes in sickle cell disease

enthalten in: Thrombosis research | 2013

von Desai, P. | Brittain, J. | Jones, S. | +6

7

A double-blind, randomized, multicenter phase 2 study of prasugrel versus placebo in adult patients with sickle cell disease

enthalten in: Journal of hematology & oncology | 2013

von Wun, T. | Soulieres, D. | Frelinger, A. | +13

8

A potent oral P-selectin blocking agent improves microcirculatory blood flow and a marker of endothelial cell injury in patients with sickle cell disease

enthalten in: American journal of hematology | 2012

von Kutlar, A. | Ataga, K. | McMahon, L. | +7

1
[1]